These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 16735377

  • 1. The key residues in the immunodominant region 353-363 of human thyroid peroxidase were identified.
    Rebuffat SA, Bresson D, Nguyen B, Péraldi-Roux S.
    Int Immunol; 2006 Jul; 18(7):1091-9. PubMed ID: 16735377
    [Abstract] [Full Text] [Related]

  • 2. Application of mouse monoclonal antibodies for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometry.
    Bossowski A, Stasiak-Barmuta A, Czarnocka B, Urban M, Dadan J.
    Autoimmunity; 2005 Dec; 38(8):605-11. PubMed ID: 16390813
    [Abstract] [Full Text] [Related]

  • 3. Key residues contributing to dominant conformational autoantigenic epitopes on thyroid peroxidase identified by mutagenesis.
    Gora M, Gardas A, Watson PF, Hobby P, Weetman AP, Sutton BJ, Banga JP.
    Biochem Biophys Res Commun; 2004 Jul 30; 320(3):795-801. PubMed ID: 15240118
    [Abstract] [Full Text] [Related]

  • 4. New insights into the conformational dominant epitopes on thyroid peroxidase recognized by human autoantibodies.
    Bresson D, Rebuffat SA, Nguyen B, Banga JP, Gardas A, Peraldi-Roux S.
    Endocrinology; 2005 Jun 30; 146(6):2834-44. PubMed ID: 15761037
    [Abstract] [Full Text] [Related]

  • 5. Localization of key amino acid residues in the dominant conformational epitopes on thyroid peroxidase recognized by mouse monoclonal antibodies.
    Godlewska M, Czarnocka B, Gora M.
    Autoimmunity; 2012 Sep 30; 45(6):476-84. PubMed ID: 22559245
    [Abstract] [Full Text] [Related]

  • 6. Directed mutagenesis in region 713-720 of human thyroperoxidase assigns 713KFPED717 residues as being involved in the B domain of the discontinuous immunodominant region recognized by human autoantibodies.
    Bresson D, Pugnière M, Roquet F, Rebuffat SA, N-Guyen B, Cerutti M, Guo J, McLachlan SM, Rapoport B, Estienne V, Ruf J, Chardès T, Péraldi-Roux S.
    J Biol Chem; 2004 Sep 10; 279(37):39058-67. PubMed ID: 15150267
    [Abstract] [Full Text] [Related]

  • 7. Structural insights into autoreactive determinants in thyroid peroxidase composed of discontinuous and multiple key contact amino acid residues contributing to epitopes recognized by patients' autoantibodies.
    Dubska M, Banga JP, Plochocka D, Hoser G, Kemp EH, Sutton BJ, Gardas A, Gora M.
    Endocrinology; 2006 Dec 10; 147(12):5995-6003. PubMed ID: 16959834
    [Abstract] [Full Text] [Related]

  • 8. Monozygotic twin pairs discordant for Hashimoto's thyroiditis share a high proportion of thyroid peroxidase autoantibodies to the immunodominant region A. Further evidence for genetic transmission of epitopic "fingerprints".
    Brix TH, Hegedüs L, Gardas A, Banga JP, Nielsen CH.
    Autoimmunity; 2011 May 10; 44(3):188-94. PubMed ID: 20883148
    [Abstract] [Full Text] [Related]

  • 9. Epitope recognition patterns of thyroid peroxidase autoantibodies in healthy individuals and patients with Hashimoto's thyroiditis*.
    Nielsen CH, Brix TH, Gardas A, Banga JP, Hegedüs L.
    Clin Endocrinol (Oxf); 2008 Oct 10; 69(4):664-8. PubMed ID: 18363888
    [Abstract] [Full Text] [Related]

  • 10. Proportion of antibodies to the A and B immunodominant regions of thyroid peroxidase in Graves and Hashimoto disease.
    Jastrzebska-Bohaterewicz E, Gardas A.
    Autoimmunity; 2004 May 10; 37(3):211-6. PubMed ID: 15497454
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of conformational epitopes on thyroid peroxidase by antipeptide antibody binding and mutagenesis.
    Gora M, Gardas A, Wiktorowicz W, Hobby P, Watson PF, Weetman AP, Sutton BJ, Banga JP.
    Clin Exp Immunol; 2004 Apr 10; 136(1):137-44. PubMed ID: 15030525
    [Abstract] [Full Text] [Related]

  • 12. Investigation of antigenic determinants in thyroid peroxidase by synthesis of possible sequential peptides.
    Hamada N, Okamoto Y, Yamakawa J, Ohno M, Noh J, Yano T, Shibata M, Ito K, Morii H.
    Osaka City Med J; 1993 Jun 10; 39(1):57-66. PubMed ID: 7694219
    [Abstract] [Full Text] [Related]

  • 13. Localization of the discontinuous immunodominant region recognized by human anti-thyroperoxidase autoantibodies in autoimmune thyroid diseases.
    Bresson D, Cerutti M, Devauchelle G, Pugnière M, Roquet F, Bes C, Bossard C, Chardès T, Péraldi-Roux S.
    J Biol Chem; 2003 Mar 14; 278(11):9560-9. PubMed ID: 12501244
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Majority of thyroid peroxidase autoantibodies in patients with autoimmune thyroid disease are directed to a single TPO domain.
    Czarnocka B, Pastuszko D, Carayon P, Ruf J, Gardas A.
    Autoimmunity; 1996 Mar 14; 23(3):145-54. PubMed ID: 8879450
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human monoclonal autoantibodies to B-cell epitopes outside the thyroid peroxidase autoantibody immunodominant region.
    Pichurin P, Guo J, Yan X, Rapoport B, McLachlan SM.
    Thyroid; 2001 Apr 14; 11(4):301-13. PubMed ID: 11349828
    [Abstract] [Full Text] [Related]

  • 20. Search for the autoantibody immunodominant region on thyroid peroxidase: epitopic footprinting with a human monoclonal autoantibody locates a facet on the native antigen containing a highly conformational epitope.
    Guo J, Yan XM, McLachlan SM, Rapoport B.
    J Immunol; 2001 Jan 15; 166(2):1327-33. PubMed ID: 11145717
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.